Literature DB >> 18179358

Does the oxidative stress in chronic obstructive pulmonary disease cause thioredoxin/peroxiredoxin oxidation?

Siri T Lehtonen1, Steffen Ohlmeier, Riitta Kaarteenaho-Wiik, Terttu Harju, Paavo Pääkkö, Ylermi Soini, Vuokko L Kinnula.   

Abstract

The thioredoxin/peroxiredoxin system comprises a redox-regulated antioxidant family in human lung; its significance, regulation, or oxidation has not been evaluated in smoking-related lung diseases. Here, we present the expression of the thioredoxin/peroxiredoxin system in lung biopsies from normal lung (n = 14), smokers (n = 21), and patients with chronic obstructive pulmonary disease (COPD, n = 38), and assess the possible inactivation/oxidation of this system by nonreducing Western blotting, two-dimensional gel electrophoresis, and mass spectrometry. Our study shows that the thiol status of the Trx/Prx-system can be modulated in vitro, but it appears to have high resistance against the oxidative stress in COPD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18179358     DOI: 10.1089/ars.2007.1952

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  8 in total

1.  Peroxiredoxin II expression and its association with oxidative stress and cell proliferation in human idiopathic pulmonary fibrosis.

Authors:  Kirsi Vuorinen; Steffen Ohlmeier; Outi Leppäranta; Kaisa Salmenkivi; Marjukka Myllärniemi; Vuokko L Kinnula
Journal:  J Histochem Cytochem       Date:  2008-07-07       Impact factor: 2.479

Review 2.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

3.  Peroxiredoxin 6 differentially regulates acute and chronic cigarette smoke–mediated lung inflammatory response and injury.

Authors:  Isaac K Sundar; Sangwoon Chung; Jae-Woong Hwang; Gnanapragasam Arunachalam; Suzanne Cook; Hongwei Yao; Witold Mazur; Vuokko L Kinnula; Aron B Fisher; Irfan Rahman
Journal:  Exp Lung Res       Date:  2010-10       Impact factor: 2.459

Review 4.  Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.

Authors:  Irfan Rahman; Vuokko L Kinnula
Journal:  Expert Rev Clin Pharmacol       Date:  2012-05       Impact factor: 5.045

5.  Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD.

Authors:  Nobuhisa Ishikawa; Steffen Ohlmeier; Kaisa Salmenkivi; Marjukka Myllärniemi; Irfan Rahman; Witold Mazur; Vuokko L Kinnula
Journal:  Respir Res       Date:  2010-09-13

Review 6.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

Review 7.  Genome-scale approaches to identify genes essential for Haemophilus influenzae pathogenesis.

Authors:  Sandy M S Wong; Brian J Akerley
Journal:  Front Cell Infect Microbiol       Date:  2012-03-05       Impact factor: 5.293

Review 8.  Progress in the mechanism and targeted drug therapy for COPD.

Authors:  Cuixue Wang; Jiedong Zhou; Jinquan Wang; Shujing Li; Atsushi Fukunaga; Junji Yodoi; Hai Tian
Journal:  Signal Transduct Target Ther       Date:  2020-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.